Literature DB >> 17101801

MEKK1 mediates the ubiquitination and degradation of c-Jun in response to osmotic stress.

Yan Xia1, Ji Wang, Shuichan Xu, Gary L Johnson, Tony Hunter, Zhimin Lu.   

Abstract

c-Jun, a major transcription factor in the activating protein 1 family of regulatory proteins, is activated by many physiologic and pathological stimuli. We show here that c-Jun was downregulated in response to osmotic stress via ubiquitination-dependent degradation by the PHD/RING finger domain of MEKK1, which exhibited E3 ubiquitin ligase activity toward c-Jun in vitro and in vivo. The reduced c-Jun protein level resulting from exogenous expression of wild-type MEKK1 and the opposite effect induced by expression of a MEKK1 PHD/RING finger domain mutant were consistent with a higher level of c-Jun protein in MEKK1(-/-) cells than in corresponding wild-type cells. The deficiency of MEKK1 blocked posttranslational downregulation of c-Jun in response to osmotic stress. Furthermore, apoptosis induced by osmotic stress was suppressed by overexpression of c-Jun, indicating that the downregulation of c-Jun promotes apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17101801      PMCID: PMC1800814          DOI: 10.1128/MCB.01355-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  48 in total

Review 1.  Diverse functions of JNK signaling and c-Jun in stress response and apoptosis.

Authors:  S Leppä; D Bohmann
Journal:  Oncogene       Date:  1999-11-01       Impact factor: 9.867

Review 2.  Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1.

Authors:  D Bohmann; T J Bos; A Admon; T Nishimura; P K Vogt; R Tjian
Journal:  Science       Date:  1987-12-04       Impact factor: 47.728

3.  Oncogene jun encodes a sequence-specific trans-activator similar to AP-1.

Authors:  P Angel; E A Allegretto; S T Okino; K Hattori; W J Boyle; T Hunter; M Karin
Journal:  Nature       Date:  1988-03-10       Impact factor: 49.962

4.  The mammalian UV response: c-Jun induction is required for exit from p53-imposed growth arrest.

Authors:  E Shaulian; M Schreiber; F Piu; M Beeche; E F Wagner; M Karin
Journal:  Cell       Date:  2000-12-08       Impact factor: 41.582

5.  The antimitogenic action of tumor necrosis factor is associated with increased AP-1/c-jun proto-oncogene transcription.

Authors:  V M Dixit; R M Marks; V Sarma; E V Prochownik
Journal:  J Biol Chem       Date:  1989-10-05       Impact factor: 5.157

Review 6.  Physiological roles of SAPK/JNK signaling pathway.

Authors:  Hiroshi Nishina; Teiji Wada; Toshiaki Katada
Journal:  J Biochem       Date:  2004-08       Impact factor: 3.387

7.  Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.

Authors:  Kanaga Sabapathy; Konrad Hochedlinger; Shin Yuen Nam; Anton Bauer; Michael Karin; Erwin F Wagner
Journal:  Mol Cell       Date:  2004-09-10       Impact factor: 17.970

8.  Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch.

Authors:  Min Gao; Tord Labuda; Ying Xia; Ewen Gallagher; Deyu Fang; Yun-Cai Liu; Michael Karin
Journal:  Science       Date:  2004-09-09       Impact factor: 47.728

9.  Human De-etiolated-1 regulates c-Jun by assembling a CUL4A ubiquitin ligase.

Authors:  Ingrid E Wertz; Karen M O'Rourke; Zemin Zhang; David Dornan; David Arnott; Raymond J Deshaies; Vishva M Dixit
Journal:  Science       Date:  2004-01-22       Impact factor: 47.728

10.  v-jun encodes a nuclear protein with enhancer binding properties of AP-1.

Authors:  T J Bos; D Bohmann; H Tsuchie; R Tjian; P K Vogt
Journal:  Cell       Date:  1988-03-11       Impact factor: 41.582

View more
  31 in total

1.  MAP/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.

Authors:  M Rafiq Islam; Tamara Jimenez; Christopher Pelham; Marianna Rodova; Sanjeev Puri; Brenda S Magenheimer; Robin L Maser; Christian Widmann; James P Calvet
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

2.  COP1 and GSK3β cooperate to promote c-Jun degradation and inhibit breast cancer cell tumorigenesis.

Authors:  Jing Shao; Yong Teng; Ravi Padia; Sungguan Hong; Hyangsoon Noh; Xiayang Xie; Jeff S Mumm; Zheng Dong; Han-Fei Ding; John Cowell; Jaejik Kim; Jiahuai Han; Shuang Huang
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

3.  c-Jun downregulation by HDAC3-dependent transcriptional repression promotes osmotic stress-induced cell apoptosis.

Authors:  Yan Xia; Ji Wang; Ta-Jen Liu; W K Alfred Yung; Tony Hunter; Zhimin Lu
Journal:  Mol Cell       Date:  2007-01-26       Impact factor: 17.970

4.  MAP3K1: Genomic Alterations in Cancer and Function in Promoting Cell Survival or Apoptosis.

Authors:  Trang T Pham; Steven P Angus; Gary L Johnson
Journal:  Genes Cancer       Date:  2013-11

5.  TRAF6 regulates satellite stem cell self-renewal and function during regenerative myogenesis.

Authors:  Sajedah M Hindi; Ashok Kumar
Journal:  J Clin Invest       Date:  2015-11-30       Impact factor: 14.808

6.  Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.

Authors:  Kavitha Sarma; Raphael Margueron; Alexey Ivanov; Vincenzo Pirrotta; Danny Reinberg
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

7.  Synaptonuclear messenger PRR7 inhibits c-Jun ubiquitination and regulates NMDA-mediated excitotoxicity.

Authors:  Dana O Kravchick; Anna Karpova; Matous Hrdinka; Jeffrey Lopez-Rojas; Sanda Iacobas; Abigail U Carbonell; Dumitru A Iacobas; Michael R Kreutz; Bryen A Jordan
Journal:  EMBO J       Date:  2016-07-25       Impact factor: 11.598

8.  Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation.

Authors:  Yeung-Tung Siu; Yick-Pang Ching; Dong-Yan Jin
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

9.  Differential regulation of c-Jun protein plays an instrumental role in chemoresistance of cancer cells.

Authors:  Yan Xia; Weiwei Yang; Wen Bu; Haitao Ji; Xueqiang Zhao; Yanhua Zheng; Xin Lin; Yi Li; Zhimin Lu
Journal:  J Biol Chem       Date:  2013-05-15       Impact factor: 5.157

10.  Muscle RING finger-1 attenuates IGF-I-dependent cardiomyocyte hypertrophy by inhibiting JNK signaling.

Authors:  Kristine M Wadosky; Jessica E Rodríguez; Rebecca L Hite; Jin-na Min; Bethany L Walton; Monte S Willis
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-01-14       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.